Fulcrum Therapeutics
IPOPublic · Cambridge, United States · Founded 2016 · $80.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- fulcrumtx.com
- Total Funding
- $80.0M
- Last Round
- $80.0M Series BSep 2018
- Rounds
- 1
- Type
- Public
About
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company developing small molecule therapies for patients with genetically defined diseases.
Summary
Fulcrum Therapeutics is a Biotech company based in Cambridge, United States, founded in 2016. It has raised $80.0M in total across 1 round, most recently a $80.0M Series B round in Sep 2018. Investors include Section 32.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...